Wuhan Keqian Biology Co Ltd
SSE:688526
Gross Margin
Wuhan Keqian Biology Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 7.8B CNY |
Gross Margin |
74%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Gross Margin |
-3%
|
Country | US |
Market Cap | 779.7B USD |
Gross Margin |
80%
|
Country | DK |
Market Cap | 4.1T DKK |
Gross Margin |
85%
|
Country | UK |
Market Cap | 440.4B GBP |
Gross Margin |
56%
|
Country | US |
Market Cap | 353B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 318B USD |
Gross Margin |
75%
|
Country | UK |
Market Cap | 189B GBP |
Gross Margin |
82%
|
Country | CH |
Market Cap | 184.2B CHF |
Gross Margin |
73%
|
Country | CH |
Market Cap | 182.3B CHF |
Gross Margin |
74%
|
Country | US |
Market Cap | 162.4B USD |
Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Wuhan Keqian Biology Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Wuhan Keqian Biology Co Ltd's most recent financial statements, the company has Gross Margin of 73.5%.